Preferences help
enabled [disable] Abstract
Number of results
2002 | 49 | 2 | 393-406
Article title

Side-chain modified vitamin D analogs require activation of both PI 3-K and erk1,2 signal transduction pathways to induce differentiation of human promyelocytic leukemia cells.

Title variants
Languages of publication
Synthetic analogs of vitamin D for potential use in differentiation therapy should selectively regulate genes necessary for differentiation without inducing any perturbations in calcium homeostasis. PRI-1906, an analog of vitamin D2, and PRI-2191, an analog of vitamin D3 bind nuclear vitamin D receptor (nVDR) with substantially lower affinity than 1,25-dihydroxyvitamin D3 (1,25-D3), but have higher differentiation-inducing activity as estimated in HL-60 leukemia cell model. To examine how their increased differentiation-inducing activity is regulated we tested the hypothesis that membrane-mediated events, unrelated to nVDR, take part in the differentiation in response to PRI-1906 and PRI-2191. The induction of leukemia cell differentiation in response to the analogs of vitamin D was inhibited by LY294002 (phosphatidylinositol 3-kinase inhibitor), PD98059 (inhibitor of MEK1,2, an upstream regulator of extracellular-signal regulated kinase) and rapamycin (p70S6K inhibitor) pointing out that activation of signal transduction pathways unrelated to nVDR is necessary for differentiation. On the other hand, inhibition of cytosolic phospholipase A2 accelerated the differentiation of HL-60 cells induced by either 1,25-D3 or by the vitamin D analogs suggesting possible existence of a feedback loop between extracellular-signal regulated kinases and phospholipase A2.
Physical description
  • Department of Reproductive Immunology, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland
  • Pharmaceutical Research Institute, Warszawa, Poland
  • Abe E, Miamura C, Sakagami H, Takeda M, Konno K, Yamazaki T, Yoshiki S, Suda T. (1981) Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A.; 78: 4990-4.
  • Brackman D, Lund-Johansen F, Aarskog D. (1995) Expression of leukocyte differentiation antigens during the differentiation of HL60 cells induced by 1,25-dihydroxyvitamin D3: comparison with the maturation of normal monocytic and granulocytic bone marrow cells. J Leukocyte Biol.; 58: 547-55.
  • Brown AJ. (2000) Mechanisms for the selective actions of vitamin D analogues. Curr Pharm Des.; 6: 701-16.
  • Chodyński M, Wojciechowska W, Halkes SJ, van de Velde J-P, Kutner A. (1997) Synthesis and in vitro evaluation of side-chain unsaturated analogs of 24a,24b-dihomo-1,25-dihydroxycholecalciferol. Steroids.; 62: 546-53.
  • Chodyński M, Krupa M, Cholinski J, Wojciechowska W, Fitak H, Zorgdrager J, van de Velde J-P, Kutner A. (2000) Synthesis and biological evaluation of active metabolites of vitamin D3 and side-chain modified analogues of vitamin D2. In Vitamin D endocrine system. structural biological genetic and clinical aspects. Norman AW, Bouillon R, Thomasset M. eds, pp 85-8. Proc Eleventh Workshop on Vitamin D. Nashville, TN.
  • Chung J, Grammer TC, Lemon KP, Kazlauskas A, Blenis J. (1994) PDGF- and insulin-dependent pp70S6K activation mediated by phosphatidylinositol-3-OH kinase. Nature.; 370: 71-5.
  • Fogh K, Kragballe K. (2000) Recent developments in vitamin D analogs. Curr Pharm Design.; 6: 961-972.
  • Geijsen N, Dijkers PF, Lammers JJ, Koenderman L, Coffer PJ. (2000) Cytokine-mediated cPLA2 phosphorylation is regulated by multiple MAPK family members. FEBS Lett.; 471: 83-8.
  • Hansen CM, Hamberg KJ, Binderup E, Binderup L. (2000) A vitamin D analogue of anti-cancer potential. Background, design, synthesis, pre-clinical and clinical evaluation. Curr Pharm Des.; 6: 803-28.
  • Helm S, Sylvia VL, Harmon T, Dean DD, Boyan BD, Schwartz Z. (1996) 24,25-(OH)2D3 regulates protein kinase C through two distinct phospholipid-dependent mechanisms. J Cell Physiol.; 169: 509-21.
  • Hmama Z, Nandan D, Sly L, Knutson KL, Herrera-Velit P, Reiner NE. (1999) 1-α,25dihydroxyvitamin D3-induced myeloid cell differentiation is regulated by a vitamin D receptor-phosphatidylinositol 3-kinase signalling complex. J Exp Med.; 190: 1583-94.
  • Ikekawa N, Ishizuka S. (1992) Molecular structure and biological activity of vitamin D metabolites and their analogs. In Molecular Structure and Biological Activity of Steroids. Bohl M, Duax WL. eds, pp 293-316. CRC Press, Boca Raton.
  • Jones G, Strugnell S.A., DeLuca H. (1998) Current understanding of the molecular actions of vitamin D. Physiol Rev.; 78: 1193-231.
  • Marcinkowska E, Więdłocha A, Radzikowski C. (1997) 1,25-Dihydroxyvitamin D3 induced activation and subsequent nuclear translocation of MAPK is upstream regulated by PKC in HL-60 cells. Biochem Biophys Res Commun.; 241: 419-26.
  • Marcinkowska E, Kutner A, Radzikowski C. (1998a) Cell differentiating and anti-proliferative activity of side-chain modified analogues of 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol.; 67: 71-8.
  • Marcinkowska E, Więdłocha A, Radzikowski C. (1998b) Evidence that phosphatidylinositol 3-kinase and p70S6K protein are involved in differentiation of HL-60 cells induced by calcitriol. Anticancer Res.; 18: 3507-14.
  • Marcinkowska E. (2001) Evidence that activation of MEK1,2/erk1,2 signal transduction pathway is necessary for calcitriol-induced differentiation of HL-60 cells. Anticancer Res.; 21: 499-504.
  • McCarthy DM, San Miguel JF, Freake HC, Green PM, Zola H, Catovsky D, Goldman JM. (1983) 1,25-Dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells. Leuk Res.; 7: 51-5.
  • Munker R, Kobayashi T, Elstner E, Norman AW, Uskokovic M, Zhang W, Andreeff M, Koeffler HP. (1996) A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia. Blood.; 88: 2201-9.
  • Nemere I, Szego CM. (1981) Early actions of parathyroid hormone and 1,25-dihydroxycholecalciferol on isolated epithelial cells from rat intestine. I. Limited lysosomal enzyme release and calcium uptake. Endocrinology.; 108: 1450-62.
  • Nemere I, Dormannen MC, Hammond MW, Okamura WH, Norman AW. (1994) Identification of specific binding for 1,25-dihydroxyvitamin D3 in basal lateral membranes of chick intestinal epithelium and relationship to transcaltachia. J Biol Chem.; 269: 23750-6.
  • Nemere I, Schwartz Z, Pedrozo H, Sylvia VL, Dean DD, Boyan BD. (1998) Identification of a membrane receptor for 1,25-dihydroxyvitamin D3 which mediates rapid activation of protein kinase C. J Bone Miner Res.; 13: 1353-9.
  • Nemere I, Campbell K. (2000) Immunochemical studies on the putative plasmalemmal receptor for 1,25(OH)2D3. III. Vitamin D status. Steroids.; 65: 451-7.
  • Norman AW, Song X, Zanello L, Bula C, Okamura WH. (1999) Rapid and genomic biological responses are mediated by different shapes of the agonist steroid hormone, 1alpha,25(OH)2vitamin D3. Steroids.; 64: 120-8.
  • Oberg F, Botling J, Nilsson K. (1993) Functional antagonism between vitamin D3 and retinoic acid in the regulation of CD14 and CD23 expression during monocytic differentiation of U-937 cells. J Immunol.; 150: 3487-95.
  • Opolski A, Wietrzyk J, Chrobak A, Marcinkowska E, Wojdat E, Kutner A, Radzikowski C. (1999) Antiproliferative activity in vitro of side-chain analogues of calcitriol against various human normal and cancer cell lines. Anticancer Res.; 19: 5217-22.
  • Pedrozo H, Schwartz Z, Rimes S, Sylvia VL, Nemere I, Posner GH, Dean, DD, Boyan BD. (1999) Physiological importance of the 1,25(OH)2D3 membrane receptor and evidence for a membrane receptor specific for 24,25(OH)2D3. J Bone Miner Res.; 14: 856-67.
  • Pietras RJ, Nemere I, Szego CM. (2001) Steroid hormone receptors in target cell membranes. Endocrine.; 14: 417-27.
  • Remold-O'Donnell E. (1988) Regulation of synthesis of macrophage adhesion molecule, a heterodimeric membrane glycoprotein. J Immunol.; 140: 1244-9.
  • Robinson MJ, Cobb MH. (1997) Mitogen-activated protein kinase pathways. Curr Opin. Cell Biol.; 9: 180-6.
  • Rochel N, Wurtz JM, Mitschler A, Klaholz B, Moras D. (2000) The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol Cell.; 5: 173-9.
  • Schwartz Z, Schlader DL, Swain LD, Boyan BD. (1988) Direct effects of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on growth zone and resting zone chondrocyte membrane alkaline phosphatase and phospholipase-A2 specific activities. Endocrinology.; 123: 2878-84.
  • Schwende H, Fitzke Ambs P, Dieter P. (1996) Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3. J Leukoc Biol.; 59: 555-61.
  • Street IP, Lin HK, Laliberte F, Ghomashchi F, Wang Z, Perrier H, Tremblay NM, Huang Z, Weech PK, Gelb MH. (1993) Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2. Biochemistry.; 32: 5935-40.
  • Suda T, Takahashi N, Martin TJ. (1995) Modulation of osteoclast differentiation. Endocr Rev.; 13(1): 66-80.
  • Tocchini-Valentini G, Rochel N, Wurtz JM, Mitschler A, Moras D. (2001) Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands. Proc Natl Acad Sci U S A.; 98: 5491-6.
  • Wang X, Rao J, Studzinski GP. (2000) Inhibition of p38 MAP kinase activity up-regulates multiple MAP kinase pathways and potentiates 1,25-dihydroxyvitamin D3-induced differentiation of human leukemia HL-60 cells. Exp Cell Res.; 258: 425-37.
  • Wang X, Studzinski GP. (2001) Activation of extracellular signal-regulated kinases (erks) defines the first phase of 1,25-dihydroxyvitamin D3-induced differentiation of HL-60 cells. J Cell Biochem.; 80: 471-7.
  • Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science.; 249: 1431-3.
  • Yamada S, Yamamoto K, Masuno H, Choi M. (2001) Three-dimensional structure-function relationship of vitamin D and vitamin D receptor model. Steroids.; 66: 177-87.
  • Yan J, Wang X, Donnelly RJ, Uskokovic MR, Studzinski GP. (2002) Signalling of monocytic differentiation by a non-hypercalcemic analog of vitamin D3, 1,25(OH)2-5,6-trans- 16-ene-vitamin D3, involves nuclear vitamin D receptor and non-nVDR-mediated pathways. J Cell Physiol.; 191: 198-207.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.